Effects of citrate dialysate in chronic dialysis: a multicentre randomized crossover study | Zendy

Michael Schmitz | Zendy; Olaf Loke | Zendy; Bernhard Fach | Zendy; Klaus Kalb | Zendy; Peter Heering | Zendy; Dirk Meinke | Zendy; P Rawer | Zendy; Jan Galle | Zendy; Justyna Kozik–Jaromin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of citrate dialysate in chronic dialysis: a multicentre randomized crossover study

Author(s) -

Michael Schmitz,

Olaf Loke,

Bernhard Fach,

Klaus Kalb,

Peter Heering,

Dirk Meinke,

P Rawer,

Jan Galle,

Justyna Kozik–Jaromin

Publication year - 2015

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfv347

Subject(s) - medicine , dialysis , crossover study , bicarbonate , creatinine , metabolic alkalosis , hemodialysis , urology , placebo , alternative medicine , pathology

Although citrate dialysate (CiDi) is regarded to be safe, dialysis modalities using higher dialysate volumes, like haemodiafiltration (HDF), may expose patients to higher citrate load and thus increase the risk of complications. We investigated the residual risk of CiDi compared with standard dialysate (StDi) in patients on different dialysis modalities and its effect on dialysis dose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research